Leahy, M. F.
~ 1900  results:
Search for persons X
?
3

ZANUBRUTINIB PLUS OBINUTUZUMAB IN PATIENTS WITH CHRONIC LYM..:

Tam, C.S. ; Quach, H. ; Nicol, A....
Hematological Oncology.  37 (2019)  S2 - p. 121-122 , 2019
 
?
6

SAFETY AND ACTIVITY OF THE HIGHLY SPECIFIC BTK INHIBITOR, B..:

Tam, C.S. ; Quach, H. ; Nicol, A....
Hematological Oncology.  35 (2017)  S2 - p. 113-113 , 2017
 
?
 
?
8

Effectiveness of a Patient Blood Management Data System in ..:

Mukhtar, S. A. ; Leahy, M. F. ; Trentino, K....
Anaesthesia and Intensive Care.  41 (2013)  2 - p. 207-215 , 2013
 
?
9

When should iron chelation therapy be considered in patient..:

Bird, R. J. ; Kenealy, M. ; Forsyth, C....
Internal Medicine Journal.  42 (2012)  4 - p. 450-455 , 2012
 
?
10

From blood transfusion to patient blood management: a new p..:

Leahy, M. F. ; Mukhtar, S. A.
Internal Medicine Journal.  42 (2012)  3 - p. 332-338 , 2012
 
?
12

Cryptococcal Immune Reconstitution Inflammatory Syndrome fo..:

Ingram, P. R. ; Howman, R. ; Leahy, M. F..
Clinical Infectious Diseases.  44 (2007)  12 - p. e115-e117 , 2007
 
?
13

Detection of hairy cell leukaemia in blood and bone marrow ..:

Tytherleigh, L. ; Taparia, M. ; Leahy, M.F.
Clinical & Laboratory Haematology.  23 (2001)  6 - p. 385-390 , 2001
 
?
14

Cross‐reactivity to porcine factor VIII of factor VIII inhi..:

Lloyd, J. V. ; Street, A. M. ; Berry, E....
Australian and New Zealand Journal of Medicine.  27 (1997)  6 - p. 658-664 , 1997
 
1-15
Related subjects